Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and tolerability of an investigational
drug for the prevention of chemotherapy-induced nausea and vomiting associated with
moderately emetogenic chemotherapy.